Guan, X.; Wang, L.; Cao, Y.; Shi, F.; Xu, H.; Ding, J.; Wu, M.; Li, H. A Erratum on Cost Effectiveness Analysis of Blonanserin Versus Ziprasidone As First-Line Treatment for Patients With Schizophrenia in China. Health Decision 2023, 1.